AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 85, Issue 3 392-394, Copyright © 1995 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loughlin, A M
Right arrow Articles by Lett, S M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loughlin, A M
Right arrow Articles by Lett, S M
The changing epidemiology of invasive bacterial infections in Massachusetts children, 1984 through 1991.

A M Loughlin, C D Marchant and S M Lett

Massachusetts Public Health Biologic Laboratories, Boston.

Coincident with the licensure of Haemophilus influenzae b conjugate vaccines from 1987 to 1990, the incidence of meningitis and other invasive infections caused by H influenzae type b declined in Massachusetts children by 87% and 91%, respectively. By 1991, Neisseria meningitidis had replaced H influenzae b as the leading cause of bacterial meningitis, accounting for 57% of cases. During the period 1984 through 1991, serogroup C displaced sero-group B as the most common cause of N meningitidis disease. Streptococcus pneumoniae caused 92% of nonmeningitis invasive disease, with sero-groups 14, 6, 19, 18, 4, 23, and 9 causing 94.5% of infections. These findings have implications for the development of additional polysaccharide-protein conjugate vaccines for the prevention of childhood infections.




This article has been cited by other articles:


Home page
JAMAHome page
Emergence of Antimicrobial-Resistant Serotype 19A Streptococcus pneumoniae Massachusetts, 2001-2006
JAMA, December 12, 2007; 298(22): 2612 - 2614.
[Full Text] [PDF]


Home page
Infect. Immun.Home page
L. A. Lewis, K. Rohde, M. Gipson, B. Behrens, E. Gray, S. I. Toth, B. A. Roe, and D. W. Dyer
Identification and Molecular Analysis of lbpBA, Which Encodes the Two-Component Meningococcal Lactoferrin Receptor
Infect. Immun., June 1, 1998; 66(6): 3017 - 3023.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Public Health Association